Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Gina Kruse

Concepts (225)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Smoking Cessation
17
2025
446
6.210
Why?
Text Messaging
5
2023
156
2.420
Why?
Early Detection of Cancer
7
2025
419
2.140
Why?
Smoking
8
2023
1633
1.660
Why?
Primary Health Care
7
2023
1714
1.320
Why?
Tobacco Use
3
2022
65
1.100
Why?
Smokers
4
2020
148
1.060
Why?
Massachusetts
8
2025
170
1.020
Why?
Colorectal Neoplasms
4
2025
792
1.010
Why?
Tobacco Products
3
2025
142
0.980
Why?
Tobacco Use Cessation
2
2024
26
0.940
Why?
Tobacco Use Disorder
3
2022
252
0.940
Why?
Electronic Nicotine Delivery Systems
5
2025
109
0.920
Why?
Buprenorphine
2
2025
167
0.840
Why?
Postal Service
2
2020
32
0.840
Why?
Uterine Cervical Neoplasms
2
2024
254
0.820
Why?
Community Health Services
2
2015
228
0.760
Why?
Laboratories
1
2023
113
0.750
Why?
United States Indian Health Service
2
2022
42
0.700
Why?
Patient Discharge
3
2024
896
0.680
Why?
Mentoring
1
2023
143
0.650
Why?
Electronic Health Records
4
2016
1036
0.650
Why?
Alaska Natives
1
2022
142
0.630
Why?
Papillomavirus Infections
1
2023
324
0.600
Why?
Health Behavior
3
2022
756
0.580
Why?
Community Health Centers
5
2025
58
0.560
Why?
Pilot Projects
6
2025
1697
0.560
Why?
Delivery of Health Care
4
2023
939
0.560
Why?
Humans
56
2025
136783
0.560
Why?
Rural Population
3
2024
561
0.530
Why?
Meaningful Use
1
2016
13
0.520
Why?
Indians, North American
1
2022
625
0.490
Why?
Middle Aged
22
2025
33200
0.490
Why?
Comorbidity
2
2017
1611
0.470
Why?
HIV Infections
7
2024
2812
0.470
Why?
Motivation
2
2019
563
0.460
Why?
Smoke-Free Policy
1
2014
15
0.450
Why?
Female
34
2025
72840
0.450
Why?
Unnecessary Procedures
1
2014
49
0.440
Why?
Opiate Substitution Treatment
3
2025
147
0.440
Why?
Smoking Prevention
1
2015
186
0.430
Why?
Telemedicine
2
2021
847
0.430
Why?
Male
30
2025
67361
0.430
Why?
Adult
26
2025
37616
0.420
Why?
Tobacco Smoking
2
2024
28
0.410
Why?
Reimbursement, Incentive
1
2013
37
0.410
Why?
Program Development
1
2015
365
0.400
Why?
Counseling
4
2024
391
0.400
Why?
Vaping
2
2025
63
0.400
Why?
Lung Neoplasms
1
2025
2491
0.380
Why?
Colonoscopy
1
2014
247
0.380
Why?
Health Equity
3
2024
99
0.370
Why?
Documentation
1
2013
189
0.360
Why?
Telephone
2
2023
170
0.360
Why?
Tobacco Smoke Pollution
1
2014
285
0.360
Why?
Population Surveillance
1
2014
470
0.350
Why?
Neoplasms
2
2023
2644
0.350
Why?
Cross-Sectional Studies
9
2025
5417
0.320
Why?
Anti-HIV Agents
2
2014
772
0.320
Why?
Hospitalization
2
2021
2195
0.310
Why?
Referral and Consultation
2
2012
777
0.290
Why?
Opioid-Related Disorders
2
2025
504
0.270
Why?
Aged
12
2025
23729
0.260
Why?
Students
2
2022
624
0.260
Why?
United States
8
2025
14660
0.260
Why?
Boston
3
2024
91
0.250
Why?
Flavoring Agents
1
2025
13
0.240
Why?
South Africa
2
2024
219
0.240
Why?
Feasibility Studies
2
2022
947
0.230
Why?
Appointments and Schedules
2
2002
89
0.230
Why?
Occult Blood
1
2024
34
0.220
Why?
Pandemics
3
2021
1619
0.220
Why?
Faculty
2
2022
144
0.220
Why?
India
2
2024
193
0.220
Why?
Patient Compliance
2
2012
576
0.210
Why?
Outpatients
2
2024
393
0.210
Why?
Mental Disorders
2
2002
1075
0.210
Why?
Social Determinants of Health
2
2024
250
0.210
Why?
Narcotic Antagonists
1
2025
178
0.200
Why?
Vaginal Smears
1
2023
56
0.200
Why?
Safety-net Providers
1
2024
117
0.190
Why?
Cooperative Behavior
1
2025
443
0.190
Why?
Papillomaviridae
1
2023
126
0.190
Why?
Outpatient Clinics, Hospital
1
2002
83
0.190
Why?
Interrupted Time Series Analysis
1
2022
66
0.190
Why?
Medically Underserved Area
1
2022
86
0.190
Why?
Treatment Refusal
1
2002
89
0.190
Why?
Student Run Clinic
1
2021
3
0.180
Why?
Mass Screening
3
2025
1262
0.180
Why?
Pain Management
1
2005
347
0.180
Why?
Tuberculosis
1
2024
279
0.180
Why?
Behavior Therapy
2
2022
257
0.180
Why?
Patient Participation
1
2005
416
0.180
Why?
Medication Adherence
1
2025
468
0.180
Why?
Education, Medical, Undergraduate
1
2023
186
0.170
Why?
Physician-Patient Relations
1
2005
544
0.170
Why?
Developing Countries
2
2015
306
0.160
Why?
Ambulatory Care
1
2024
538
0.160
Why?
Prevalence
4
2025
2712
0.160
Why?
Interviews as Topic
3
2019
766
0.160
Why?
Longitudinal Studies
2
2020
2847
0.160
Why?
Community Networks
1
2020
59
0.160
Why?
Education, Medical
1
2023
260
0.160
Why?
Crisis Intervention
1
2019
33
0.160
Why?
Pain
1
2005
755
0.160
Why?
Analgesics, Opioid
2
2024
991
0.150
Why?
Preventive Health Services
1
2020
148
0.150
Why?
Nevirapine
2
2008
17
0.140
Why?
Cohort Studies
5
2025
5718
0.140
Why?
Students, Medical
1
2023
341
0.140
Why?
Young Adult
6
2025
13126
0.140
Why?
Decision Making
1
2005
896
0.140
Why?
Organophosphonates
2
2008
92
0.140
Why?
Surveys and Questionnaires
4
2019
5749
0.130
Why?
Randomized Controlled Trials as Topic
2
2022
1455
0.130
Why?
Communication
1
2023
869
0.130
Why?
Deoxycytidine
2
2008
175
0.130
Why?
Adolescent
8
2025
21463
0.130
Why?
Caregivers
1
2024
873
0.130
Why?
Liver Transplantation
1
2024
871
0.130
Why?
Pneumonia, Viral
1
2021
368
0.130
Why?
Texas
4
2005
246
0.130
Why?
Infectious Disease Transmission, Vertical
2
2008
182
0.120
Why?
Diabetes Mellitus
1
2024
1033
0.120
Why?
Adenine
2
2008
267
0.120
Why?
Diffusion of Innovation
1
2016
98
0.120
Why?
Focus Groups
2
2022
508
0.120
Why?
Hypertension
1
2024
1284
0.120
Why?
Allied Health Personnel
1
2015
45
0.120
Why?
Qualitative Research
2
2019
1359
0.120
Why?
Community Health Workers
1
2015
61
0.110
Why?
Automobiles
1
2014
19
0.110
Why?
Health Surveys
1
2017
517
0.110
Why?
Uganda
1
2014
72
0.110
Why?
Logistic Models
3
2017
2060
0.110
Why?
Colonic Polyps
1
2014
88
0.100
Why?
Odds Ratio
3
2008
1063
0.100
Why?
Program Evaluation
2
2020
886
0.100
Why?
Residence Characteristics
2
2014
354
0.100
Why?
Patient Admission
1
2014
191
0.100
Why?
Research Design
1
2019
1107
0.100
Why?
Managed Care Programs
1
2013
129
0.100
Why?
Health Services Accessibility
4
2024
976
0.100
Why?
Hospitals, Psychiatric
2
2002
26
0.100
Why?
Stress, Psychological
1
2021
1098
0.100
Why?
Patient Acceptance of Health Care
3
2022
806
0.100
Why?
Social Class
1
2014
277
0.090
Why?
Prospective Studies
3
2025
7583
0.090
Why?
HIV-1
2
2008
857
0.090
Why?
Nurses
1
2014
173
0.090
Why?
Feedback
1
2012
173
0.090
Why?
Health Plan Implementation
1
2012
137
0.090
Why?
Quality Assurance, Health Care
1
2013
322
0.090
Why?
Follow-Up Studies
2
2024
5115
0.090
Why?
Emergency Service, Hospital
1
2022
2050
0.090
Why?
Hospitals
1
2014
677
0.080
Why?
Diabetes Mellitus, Type 2
1
2022
2512
0.070
Why?
Retrospective Studies
4
2022
15564
0.070
Why?
Reverse Transcriptase Inhibitors
1
2007
84
0.070
Why?
Patient Care Team
1
2012
627
0.070
Why?
Chronic Disease
1
2013
1784
0.070
Why?
Drug Resistance, Viral
1
2007
115
0.070
Why?
Renal Insufficiency
1
2008
156
0.060
Why?
Anti-Retroviral Agents
1
2008
232
0.060
Why?
Insurance, Health
2
2005
278
0.060
Why?
Aged, 80 and over
4
2024
7569
0.060
Why?
Behavioral Risk Factor Surveillance System
1
2025
51
0.060
Why?
Risk Factors
2
2014
10331
0.060
Why?
Regression Analysis
2
2005
1024
0.060
Why?
Insurance Coverage
2
2022
228
0.050
Why?
Vaccination
2
2022
1378
0.050
Why?
Pregnancy Complications, Infectious
1
2008
389
0.050
Why?
Quality Improvement
1
2012
1152
0.050
Why?
Drug Therapy, Combination
2
2022
1059
0.050
Why?
Housing
1
2024
147
0.050
Why?
Social Networking
1
2023
34
0.050
Why?
Rural Health Services
1
2004
127
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2022
64
0.050
Why?
Mobile Health Units
1
2022
21
0.050
Why?
Health Status
2
2005
781
0.050
Why?
Health Services for the Aged
1
2003
73
0.050
Why?
Midwestern United States
1
2002
45
0.050
Why?
Hospitals, University
1
2002
180
0.050
Why?
Varenicline
1
2022
25
0.050
Why?
Bupropion
1
2022
45
0.050
Why?
Quality of Life
2
2022
2868
0.050
Why?
Stakeholder Participation
1
2022
75
0.050
Why?
Antiviral Agents
1
2007
736
0.050
Why?
Schools, Medical
1
2023
146
0.050
Why?
Continuity of Patient Care
1
2004
278
0.050
Why?
England
1
2021
99
0.040
Why?
Vulnerable Populations
1
2022
163
0.040
Why?
Meals
1
2022
124
0.040
Why?
HIV
1
2022
233
0.040
Why?
Data Collection
1
2024
664
0.040
Why?
Minority Groups
1
2022
267
0.040
Why?
Poverty
1
2024
519
0.040
Why?
Urban Population
1
2003
472
0.040
Why?
Triage
1
2021
220
0.040
Why?
Learning
1
2023
414
0.040
Why?
Medicaid
1
2003
433
0.040
Why?
Zambia
2
2008
57
0.040
Why?
Treatment Outcome
1
2012
10764
0.030
Why?
Medicare
1
2003
747
0.030
Why?
Practice Guidelines as Topic
1
2025
1568
0.030
Why?
Emtricitabine
2
2008
174
0.030
Why?
Tenofovir
2
2008
240
0.030
Why?
Curriculum
1
2023
979
0.030
Why?
Child
2
2024
21968
0.020
Why?
Case-Control Studies
1
2017
3537
0.020
Why?
Socioeconomic Factors
2
2004
1281
0.020
Why?
Chi-Square Distribution
1
2008
532
0.020
Why?
Antiretroviral Therapy, Highly Active
1
2008
269
0.020
Why?
Creatinine
1
2008
498
0.020
Why?
Risk
1
2008
904
0.020
Why?
Proportional Hazards Models
1
2008
1260
0.010
Why?
Pregnancy
2
2008
6731
0.010
Why?
Glomerular Filtration Rate
1
2008
744
0.010
Why?
Health Status Indicators
1
2004
171
0.010
Why?
Office Visits
1
2003
90
0.010
Why?
Health Care Surveys
1
2003
563
0.010
Why?
Disease Progression
1
2008
2750
0.010
Why?
Biomarkers
1
2008
4158
0.010
Why?
Infant, Newborn
1
2007
6046
0.010
Why?
Health Knowledge, Attitudes, Practice
1
2004
1323
0.010
Why?
Kruse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)